BioCentury
ARTICLE | Company News

Arrow in RSV deal with Virogen

December 1, 2000 8:00 AM UTC

Arrow Therapeutics (London, U.K.) and Virogen (London, U.K.) will develop therapeutics to treat respiratory syncytial virus (RSV). Arrow will provide its compound library to Virogen, which will screen...